No Data
No Data
Imugene Appoints CFO; Shares Fall 3%
Clinuvel Pharmaceuticals Price Target Cut 2.2% to A$21.75/Share by Bell Potter
Clinuvel Pharmaceuticals Ltd: Half Year Results Presentation
Clinuvel Pharmaceuticals Ltd: Half Year Results Announcement
Clinuvel Pharmaceuticals Ltd: Appendix 4D and Half Year Report
Clinuvel Pharmaceuticals Ltd: CLINUVEL Investor Webinar